LINC02151

Across TCGA pan-cancer cohorts, LINC02151 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02151 data layer.

The strongest signal is observed in thymoma (THYM), where higher LINC02151 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02151 expression acts as an unfavorable survival marker, although some lineages such as LGG and LIHC show a favorable association.

THYM, ACC, and DLBC are the cancer types where LINC02151 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	All	0.418	0.878	<.001	144	view →
ACC	OS	Tertile	All	0.246	0.817	<.001	90	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	46	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	45	view →
LGG	DFS	Median	All	0.806	0.665	<.001	42	view →
LIHC	OS	Tertile	All	0.650	0.466	<.001	42	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	27	view →
UCEC	DFS	Tertile	All	0.496	0.664	.001	24	view →
PAAD	OS	Tertile	II,III,IV	0.244	0.561	.003	18	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	18	view →
COAD	DFS	Tertile	III,IV	0.261	0.657	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02151–THYM (DFS)

Open the THYM breakdown →